C12Y 207/01003
Ketohexokinase
Official title: Ketohexokinase (2.7.1.3)
C12Y207/01003 (Ketohexokinase) appears on 1 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 10
- Assignees
- 4
- Inventors
- 26
- Latest grant
- 28 Apr 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 3 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Ketohexokinase (khk) irna compositions and methods of use thereof14 Aug 2025US 2025/0257358 A1Alnylam Pharmaceuticals, Inc.
- Engineered immune cell13 Feb 2025US 2025/0049917 A1King's College London
- Ketohexokinase (khk) irna compositions and methods of use thereof16 May 2024US 2024/0158796 A1Alnylam Pharmaceuticals, Inc.
- Methods for the treatment of nash with advanced fibrosis and/or cirrhosis9 May 2024US 2024/0150768 A1Boehringer Ingelheim International GmbH
- Dosage regimen for the treatment of nash2 May 2024US 2024/0139230 A1Boehringer Ingelheim International GmbH
Most cited
By later US patents